Home Business & Economics

Business & Economics

Photo Courtesy: © 2020 Karius Inc.

Karius Secures US $165 M Series B Funding; Expands Access to...

Peter Hofland, Ph.D -
Featured Image: Cancerous cells forming a lump in the pancreatic tissue. Photo courtesy: Scientific Animations. Licensed under the Creative Commons Attribution-Share Alike 4.0 International license.

Phase II Trial of Cabiralizumab + Nivolumab Does Not Meet Primary...

Peter Hofland, Ph.D -

TrialJectory Partners with Precipio, Providing Patients with Diagnostics + Clinical Trial...

Peter Hofland, Ph.D -

Immunotherapy Market Estimated to Reach U.S. $115 Billion by 2023

Editorial Team -

Seattle Genetics Submits New Drug Application to the U.S. FDA for...

Peter Hofland, Ph.D -
Featured Image: Pink breast cancer awareness. Photo courtesy: 2019 Fotolia.

Trastuzumab deruxtecan Approved for the Treatment of Metastatic HER2-positive Breast Cancer

Peter Hofland, Ph.D -
Belong.Life, the world's largest social network for cancer patients, expands to South Africa. Photo Courtesy: 2019 SVC

Belong.Life Broadens Global Impact

Peter Hofland, Ph.D -
Featured Image: WuXi STA and Impact Therapeutics, a Chinese clinical-stage biopharmaceutical company dedicated to the discovery and development of anti-cancer drugs, have signed a partnership agreement in which WuXi STA will become the preferred CDMO partner for Impact Therapeutics

WuXi STA and Impact Therapeutics Sign Strategic Partnership

Peter Hofland, Ph.D -
SurVaxM. Photo Courtesy: 2019 Roswell Park.

Large Phase II Study to Investigate SurVaxM in Glioblastoma in China...

Peter Hofland, Ph.D -
Noona® software application is a smart, cloud-based patient-reported outcomes (PRO) solution. Through the capture and analysis of structured, real-time symptom information, Noona helps clinicians better manage patient symptoms and improve treatment outcomes. Noona is designed to support the everyday work of nurses and physicians in cancer care, helping to increase clinical efficiency and reduce workloads through comprehensive communications tools.

Michigan Oncology Quality Consortium Selects Varian to Support Transition to Value-Based...

Peter Hofland, Ph.D -
123...9Page 1 of 9

LATEST

© 2020 Sunvalley Communication, LLC. All Rights Reserved.